Oncology | Novartis United States of America

Story
Jul 29, 2024
A Journey of Compassion: From Pharmacy to Oncology Sales
Story
Nov 10, 2023
Remembering men’s health this National Veterans and Military Families Month
Media Release
Oct 26, 2023
Novartis confirms unconstrained supply for Pluvicto® and continues to significantly expand the number of treatment centers
Media Release
Mar 17, 2023
Novartis Tafinlar + Mekinist approved by FDA for pediatric patients with BRAF V600E low-grade glioma, the most common pediatric brain cancer